+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence against the release of a remotely produced skeletal muscle vaso dilator substance during oligemic shock

Evidence against the release of a remotely produced skeletal muscle vaso dilator substance during oligemic shock

Federation Proceedings 36(3): 583

(PDF emailed within 1 workday: $29.90)

Accession: 026590973

Download citation: RISBibTeXText

Related references

Release of a humoral vaso dilator substance during neurogenic vaso dilatation. Circulations3: 39, 1969

Release of vaso dilator substances in sepsis and septic shock abstract dog. Federation Proceedings 28(2): 615, 1969

The functional significance of the sympathetic vaso dilator effect in skeletal muscle. Doklady Biological Sciences 197(1-6): (1972), 1971

Impulse response of the skeletal muscle metabolic vaso dilator system. Federation Proceedings 30(2): 211, 1971

Mechanism of escape of skeletal muscle resistance vessels from the influence of sympathetic cholinergic vaso dilator fiber activity cat dog. Acta Physiologica Scandinavica 72(1/2): 148-156, 1968

Evidence against a local metabolic deficit being responsible for skeletal muscle vascular decompensation during oligemic hypotension. Federation Proceedings 37(3): 369, 1978

Influence of vaso dilator therapy on prognosis of acute myo cardial infarction in aged patients a comparative study between a vaso dilator treated group and a group treated without vaso dilators. Japanese Heart Journal 21(1): 35-46, 1980

Paradoxical inhibition of vaso constrictor and vaso dilator responses by hypertonic mannitol in isolated arterial smooth muscle. European Journal of Pharmacology 58(4): 379-388, 1979

Evaluation of splanchnic artery occlusion plasma for a skeletal muscle vascular dilator substance. Circulatory Shock 3(3): 231-238, 1976

Vaso dilator action and therapeutic effectiveness of vaso dilator agents. Japanese Journal of Medicine 21(4): 279, 1982

Paradoxical reflex skeletal muscle vaso constriction produced by prostaglandin f 2 alpha. Pharmacologist 18(2): 140, 1976

Reassessment of the effects of vaso dilator drugs in primary pulmonary hypertension guidelines for determining a pulmonary vaso dilator response. American Heart Journal 105(1): 119-127, 1983

Release of vaso dilator prostaglandin prostaglandin i 2 from isolated rat lung during vaso constriction. Circulation Research 48(2): 207-213, 1981

Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium. British Journal of Pharmacology 97(3): 983-989, 1989